{"id":"https://openalex.org/W2993619082","doi":"https://doi.org/10.2217/cer-2019-0127","title":"Does evidence matter? Comparative effectiveness research and prescribing of Type 2 diabetes mellitus drugs","display_name":"Does evidence matter? Comparative effectiveness research and prescribing of Type 2 diabetes mellitus drugs","publication_year":2019,"publication_date":"2019-12-01","ids":{"openalex":"https://openalex.org/W2993619082","doi":"https://doi.org/10.2217/cer-2019-0127","mag":"2993619082","pmid":"https://pubmed.ncbi.nlm.nih.gov/31789054"},"language":"en","primary_location":{"id":"doi:10.2217/cer-2019-0127","doi":"https://doi.org/10.2217/cer-2019-0127","is_oa":false,"landing_page_url":"https://doi.org/10.2217/cer-2019-0127","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080147908","display_name":"Prachi Arora","orcid":"https://orcid.org/0000-0002-7057-9033","observed_orcids":["https://orcid.org/0000-0002-7057-9033"]},"institutions":[{"id":"https://openalex.org/I110678235","display_name":"Butler University","ror":"https://ror.org/05gq3a412","country_code":"US","type":"education","lineage":["https://openalex.org/I110678235"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Prachi Arora","raw_affiliation_strings":["College of Pharmacy & Health Sciences, Butler University, 4600 Sunset Ave, Indianapolis, IN 46208, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy & Health Sciences, Butler University, 4600 Sunset Ave, Indianapolis, IN 46208, USA","institution_ids":["https://openalex.org/I110678235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065863066","display_name":"Kevin A. Look","orcid":"https://orcid.org/0000-0003-3615-9059","observed_orcids":["https://orcid.org/0000-0003-3615-9059"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin A Look","raw_affiliation_strings":["Social & Administrative Sciences Division, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705-2222, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Social & Administrative Sciences Division, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705-2222, USA","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002366103","display_name":"David H. Kreling","orcid":"https://orcid.org/0000-0003-2302-6441","observed_orcids":["https://orcid.org/0000-0003-2302-6441"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David H Kreling","raw_affiliation_strings":["Social & Administrative Sciences Division, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705-2222, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Social & Administrative Sciences Division, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705-2222, USA","institution_ids":["https://openalex.org/I135310074"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5080147908"],"corresponding_institution_ids":["https://openalex.org/I110678235"],"apc_list":null,"apc_paid":null,"fwci":0.2029,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.61531753,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"8","issue":"16","first_page":"1393","last_page":"1403"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.04639999940991402,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.018200000748038292,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/comparative-effectiveness-research","display_name":"comparative effectiveness research","score":0.906000018119812},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9769999980926514},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.7710000276565552},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8349999785423279},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9390000104904175},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9760000109672546},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/evidence-to-practice-translation","display_name":"evidence-to-practice translation","score":0.7179999947547913},{"id":"https://openalex.org/keywords/drug-market-entry","display_name":"drug market entry","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.9446642994880676},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9344593286514282},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.8748564124107361},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.8057808876037598},{"id":"https://openalex.org/C2778111679","wikidata":"https://www.wikidata.org/wiki/Q5155639","display_name":"Comparative effectiveness research","level":3,"score":0.5847095847129822},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5240355134010315},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.49255070090293884},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4156579375267029},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.411072313785553},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4033389389514923},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37628936767578125},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3621891736984253},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.35184091329574585},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1813976764678955},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008389","descriptor_name":"Marketing of Health Services","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011307","descriptor_name":"Drug Prescriptions","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D057186","descriptor_name":"Comparative Effectiveness Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2217/cer-2019-0127","doi":"https://doi.org/10.2217/cer-2019-0127","is_oa":false,"landing_page_url":"https://doi.org/10.2217/cer-2019-0127","pdf_url":null,"source":{"id":"https://openalex.org/S2489859990","display_name":"Journal of Comparative Effectiveness Research","issn_l":"2042-6305","issn":["2042-6305","2042-6313"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Comparative Effectiveness Research","raw_type":"journal-article"},{"id":"pmid:31789054","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31789054","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of comparative effectiveness research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W27654371","https://openalex.org/W1889580427","https://openalex.org/W1965727529","https://openalex.org/W1965753048","https://openalex.org/W1974876098","https://openalex.org/W2000928685","https://openalex.org/W2001094634","https://openalex.org/W2012889216","https://openalex.org/W2018606165","https://openalex.org/W2021645358","https://openalex.org/W2027624580","https://openalex.org/W2033185429","https://openalex.org/W2054754778","https://openalex.org/W2059678666","https://openalex.org/W2067877381","https://openalex.org/W2068424571","https://openalex.org/W2071806619","https://openalex.org/W2083415436","https://openalex.org/W2086682814","https://openalex.org/W2088625643","https://openalex.org/W2091214805","https://openalex.org/W2092287139","https://openalex.org/W2094375923","https://openalex.org/W2106963009","https://openalex.org/W2114927834","https://openalex.org/W2116254891","https://openalex.org/W2117958352","https://openalex.org/W2118285639","https://openalex.org/W2118762421","https://openalex.org/W2124492501","https://openalex.org/W2132800868","https://openalex.org/W2138897693","https://openalex.org/W2141132900","https://openalex.org/W2146668368","https://openalex.org/W2152984355","https://openalex.org/W2153007670","https://openalex.org/W2159920024","https://openalex.org/W2163708304","https://openalex.org/W2167042818","https://openalex.org/W2167651200","https://openalex.org/W2168226052","https://openalex.org/W2169490447","https://openalex.org/W2169816221","https://openalex.org/W2170606300","https://openalex.org/W2265629955","https://openalex.org/W2276028032","https://openalex.org/W2312549738","https://openalex.org/W2419008976","https://openalex.org/W2475260156","https://openalex.org/W2513403311","https://openalex.org/W2792936728","https://openalex.org/W3025748272","https://openalex.org/W3092065440","https://openalex.org/W3140709557","https://openalex.org/W6684453849","https://openalex.org/W7075647042"],"related_works":["https://openalex.org/W2282034610","https://openalex.org/W2472478543","https://openalex.org/W4375853450","https://openalex.org/W1985556035","https://openalex.org/W2419008976","https://openalex.org/W4383302696","https://openalex.org/W2731725953","https://openalex.org/W2563013373","https://openalex.org/W2123690908","https://openalex.org/W2743088090"],"abstract_inverted_index":{"Aim:":[0],"Comparative":[1],"effectiveness":[2],"research":[3,14],"(CER)":[4],"can":[5,149],"help":[6],"ascertain":[7],"value":[8],"of":[9,18,25,42,83,86,145,155,160],"new":[10],"drugs;":[11],"however,":[12,134],"limited":[13,151],"assesses":[15],"the":[16,31,53,97,113,153],"translation":[17,144],"CER":[19,34,67,80,105,121],"into":[20,147],"clinical":[21],"practice.":[22],"The":[23,143],"objective":[24],"this":[26],"study":[27],"was":[28,71],"to":[29,51,58,65,117,124],"analyze":[30],"association":[32],"between":[33],"evidence":[35,122,146],"and":[36,60,158],"prescribing":[37,54,128],"trends":[38,55,129],"within":[39],"two":[40],"markets":[41],"Type":[43],"2":[44],"diabetes":[45],"mellitus.":[46],"Methods:":[47],"A":[48],"retrospective":[49],"analysis":[50],"determine":[52],"from":[56],"2006":[57],"2016":[59],"an":[61],"electronic":[62],"literature":[63],"search":[64],"identify":[66],"comparing":[68],"different":[69],"drugs":[70],"conducted.":[72],"Results:":[73],"In":[74,99],"glucagon-like":[75],"peptide-1":[76],"(GLP-1)":[77],"agonists":[78,132],"market,":[79,104],"showed":[81],"superiority":[82,156],"Liraglutide.":[84],"Prescribing":[85],"Exenatide":[87],"twice":[88],"daily":[89],"dropped":[90],"by":[91,152],"50%":[92],"points":[93],"as":[94],"Liraglutide":[95],"entered":[96],"market.":[98,142],"dipeptidyl":[100],"peptidase-4":[101],"(DPP4)":[102],"inhibitors":[103,141],"did":[106],"not":[107],"suggest":[108],"conclusive":[109],"superiority.":[110],"Nevertheless,":[111],"Sitagliptin,":[112],"first":[114],"entrant,":[115],"continued":[116],"dominate":[118],"throughout.":[119],"Conclusion:":[120],"appeared":[123],"be":[125,150],"associated":[126],"with":[127],"in":[130,139],"GLP-1":[131],"market;":[133],"no":[135],"associations":[136],"were":[137],"found":[138],"DPP4":[140],"practice":[148],"availability":[154],"trials":[157],"timing":[159],"their":[161],"availability.":[162]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-12-13T00:00:00"}